Filter
530
Filtered Results: 530
Text search:
fin
de
la
tb
Featured
Recommendations
30
New Publications
103
Language
Document type
No document type
253
Guidelines
116
Studies & Reports
78
Strategic & Response Plan
28
Manuals
25
Training Material
10
Fact sheets
8
Situation Updates
7
Brochures
4
Infographics
1
Countries / Regions
Senegal
38
Peru
28
Colombia
28
Latin America and the Carribbean
25
Congo, Democratic Republic of
24
Paraguay
24
Argentina
22
Bolivia
19
Haiti
18
El Salvador
15
Burkina Faso
14
Benin
14
Venezuela
11
Central African Republic
10
Rwanda
9
Madagascar
9
Cameroon
8
Ecuador
8
Global
8
Chile
6
Western and Central Europe
5
Uruguay
4
Niger
3
Cambodia
3
Guinea
2
Togo
2
Kenya
2
Honduras
2
Nicaragua
2
Africa
2
Eastern Europe
2
Sierra Leone
1
Liberia
1
Morocco
1
Ethiopia
1
Germany
1
Chad
1
Malawi
1
Dominican Republic
1
Brazil
1
Burundi
1
Ukraine
1
Guatemala
1
Mexico
1
East and Southern Africa
1
West and Central Africa
1
Tajikistan
1
Romania
1
Tunisia
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
304
Clinical Guidelines
37
Public Health
14
Key Resources
7
Women & Child Health
5
Pharmacy & Technologies
5
Toolboxes
TB
192
HIV
30
COVID-19
25
AMR
14
NTDs
9
Mental Health
8
Polio
6
Ebola
4
Rapid Response
4
Disability
3
Social Ethics
3
Caregiver
3
Pharmacy
3
Cholera
2
Refugee
2
Zika
2
NCDs
2
Natural Hazards
1
Health Financing Toolbox
1
Thousands of HIV-positive Venezuelans have been forced to leave the country, after facing discrimination and zero treatment options, according to UNAIDS.
Patients once received free ARV treatment under Venezuela’s National AIDS Program. In 2017, the country essentially ran out of ARVs—about 9 p...
Public Health Risk Analysis and Surveillance
Public Health Surveillance Protocol Tuberculosis
Le taux de rétention est un indicateur essentiel du programme. C’est une occasion pour les différents acteurs d’évaluer les progrès réalisés dans le maintien en vie des adultes et des enfants infectés qui sont mis sous traitement antirét...
The objective of the study was the validation and implementation of GeneXpert MTB/RIF for routine use in the rapid detection of tuberculosis and sensitivity to rifampicin in clinical samples; for this, 1592 respiratory samples were collected and analyzed in the laboratory of Instituto Nacional ... Investigación en Salud Pública Guayaquil. The analysis of the results of GeneXpert in comparison with smear microscopy showed an initial sensitivity of 99.8% and specificity of 93.2%; The analysis of discrepancies using the results of the culture as a reference method showed that the GeneXpert results considered false negatives turned out to be true negatives, the same happens with the false positives that correspond to true positives. Recalculated the sensitivity and specificity of the GeneXpert was 99.8% and 100% correspondingly. The comparison with the drugs susceptibility test showed a sensitivity of 91.4% and a specificity of 95.5% for the GeneXpert MTB/RIF system. It is concluded that the implementation of the GeneXpert system allows solution to certain problems associated with the application of conventional diagnostic methodologies, decreasing the waiting times, and increasing the sensitivity and specificity in the diagnosis of drug-resistant tuberculosis, thus generating a valuable opportunity for early diagnosis.
Tuberculosis "Disease of Many, everyone's fight''
- Guía de recomendaciones - 2da. Edición. Esta guía cuenta con recomendaciones e información fundamental.
Haïti: DHS 2016-2017 - Key Indicators Report (French)
